Published April 8, 2011 | Version v1
Journal article

Inverse agonist-like action of cadmium on G-protein-gated inward-rectifier K+ channels

  • 1. Center for Advanced Medical Engineering and Informatics, Osaka University, Osaka (Japan)
  • 2. Department of Pharmacology, Graduate School of Medicine, Osaka University, Osaka (Japan)
  • 3. Laboratory of Protein Informatics, Institute for Protein Research, Osaka University, Osaka (Japan)
  • 4. Laboratory of Supramolecular Crystallography, Institute for Protein Research, Osaka University, Osaka (Japan)

Description

Highlights: → We examined allosteric control of K+ channel gating. → We identified a high-affinity site for Cd2+ to inhibit Kir3.2 activity. → The 6-coordination geometry supports the binding. → Cd2+ inhibits Kir3.2 by trapping the conformation in the closed state. -- Abstract: The gate at the pore-forming domain of potassium channels is allosterically controlled by a stimulus-sensing domain. Using Cd2+ as a probe, we examined the structural elements responsible for gating in an inward-rectifier K+ channel (Kir3.2). One of four endogenous cysteines facing the cytoplasm contributes to a high-affinity site for inhibition by internal Cd2+. Crystal structure of its cytoplasmic domain in complex with Cd2+ reveals that octahedral coordination geometry supports the high-affinity binding. This mode of action causes the tethering of the N-terminus to CD loop in the stimulus-sensing domain, suggesting that their conformational changes participate in gating and Cd2+ inhibits Kir3.2 by trapping the conformation in the closed state like 'inverse agonist'.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2011.03.025

Additional details

Identifiers

DOI
10.1016/j.bbrc.2011.03.025;
PII
S0006-291X(11)00398-6;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
407
Journal Issue
2
Journal Page Range
p. 366-371
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.